|
|
Volumn 19, Issue 1, 2011, Pages 287-294
|
|
Design, synthesis, and biological evaluation of N-acetyl-S-(p- chlorophenylcarbamoyl)cysteine and its analogs as a novel class of anticancer agents
a
|
|
Author keywords
Anticancer activity; Apoptosis; Cell cycle distribution; Structure activity relationship; Synthesis
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYSTEINE DERIVATIVE;
DACARBAZINE;
N ACETYL (2,5 DIMETHOXYPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (3 CHLOROPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (3,5 DICHLOROPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (4 BROMOPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (4 CHLOROBENZYLCARBAMOYL)CYSTEINE;
N ACETYL (4 CHLOROPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (4 FLUOROPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (4 IODOPHENYLCARBAMOYL)CYSTEIN;
N ACETYL (4 METHOXYPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (NAPHTHALEN 1 YLCARBAMOYL)CYSTEINE;
N ACETYL (O CHLORO 4 NITROPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (O CHLOROPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (O FLUOROPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (O METHOXYBENZYLCARBAMOYL)CYSTEINE;
N ACETYL (O METHOXYPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (O METHYLSULFANYLPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (O NITRO 4 TRIFLUOROMETHYLPHENYLCARBAMOYL)CYSTEINE;
N ACETYL (PHENYLCARBAMOYL)CYSTEINE;
SULOFENUR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER CELL CULTURE;
CANCER INHIBITION;
CELL CYCLE;
CELL CYCLE G2 PHASE;
CELL CYCLE M PHASE;
CONTROLLED STUDY;
DNA CONTENT;
DRUG CYTOTOXICITY;
DRUG DESIGN;
DRUG POTENCY;
DRUG PROTEIN BINDING;
DRUG SCREENING;
DRUG SOLUBILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
FLOW CYTOMETRY;
HAPLORHINI;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
KIDNEY CELL;
MELANOMA;
MELANOMA CELL;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL LINE, TUMOR;
CYSTEINE;
DRUG DESIGN;
FLOW CYTOMETRY;
HUMANS;
SOLUBILITY;
STRUCTURE-ACTIVITY RELATIONSHIP;
SULFONYLUREA COMPOUNDS;
|
|
EID: 78650728228
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.11.026 Document Type: Article |
|
Times cited : (8)
|
|
References (19)
|
